Literature DB >> 21983838

Radioembolisation of hepatocellular carcinoma patients using ⁹⁰Y-labelled microspheres: towards a diffusion of the technique?

Etienne Garin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21983838     DOI： 10.1007/s00259-011-1952-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

1.  Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.

Authors:  Etienne Garin; Laurence Lenoir; Yan Rolland; Julien Edeline; Habiba Mesbah; Sophie Laffont; Philippe Porée; Bruno Clément; Jean-Luc Raoul; E Boucher
Journal:  J Nucl Med       Date:  2012-02       Impact factor: 10.057

2.  Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

Authors:  Philip Hilgard; Monia Hamami; Amr El Fouly; André Scherag; Stefan Müller; Judith Ertle; Till Heusner; Vito R Cicinnati; Andreas Paul; Andreas Bockisch; Guido Gerken; Gerald Antoch
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

3.  Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital.

Authors:  Bieke Lambert; Emiel Sturm; Jeroen Mertens; Ruth Oltenfreiter; Peter Smeets; Roberto Troisi; Hans Van Vlierberghe; Luc Defreyne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-27       Impact factor: 9.236

Review 4.  Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature.

Authors:  Steven Naymagon; Richard R P Warner; Kalpesh Patel; Noam Harpaz; Josef Machac; Joshua L Weintraub; Michelle K Kim
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

Review 5.  Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.

Authors:  C Chiesa; M Maccauro; R Romito; C Spreafico; S Pellizzari; A Negri; C Sposito; C Morosi; E Civelli; R Lanocita; T Camerini; C Bampo; S Bhoori; E Seregni; A Marchianò; V Mazzaferro; E Bombardieri
Journal:  Q J Nucl Med Mol Imaging       Date:  2011-04       Impact factor: 2.346

6.  Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

Authors:  Kent T Sato; Robert J Lewandowski; Mary F Mulcahy; Bassel Atassi; Robert K Ryu; Vanessa L Gates; Albert A Nemcek; Omar Barakat; Al Benson; Robert Mandal; Mark Talamonti; Ching-Yee O Wong; Frank H Miller; Steven B Newman; John M Shaw; Kenneth G Thurston; Reed A Omary; Riad Salem
Journal:  Radiology       Date:  2008-03-18       Impact factor: 11.105

7.  Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

Authors:  Riad Salem; Robert J Lewandowski; Mary F Mulcahy; Ahsun Riaz; Robert K Ryu; Saad Ibrahim; Bassel Atassi; Talia Baker; Vanessa Gates; Frank H Miller; Kent T Sato; Ed Wang; Ramona Gupta; Al B Benson; Steven B Newman; Reed A Omary; Michael Abecassis; Laura Kulik
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682
  7 in total
  2 in total

1.  Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience.

Authors:  Héloïse Bourien; Xavier Palard; Yan Rolland; Fanny Le Du; Luc Beuzit; Thomas Uguen; Samuel Le Sourd; Marc Pracht; Vincent Manceau; Astrid Lièvre; Karim Boudjema; Etienne Garin; Julien Edeline
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-29       Impact factor: 9.236

Review 2.  Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.

Authors:  Etienne Garin; Yan Rolland; Sophie Laffont; Julien Edeline
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.